Age at onset in genetic prion disease and the design of preventive clinical trialsEric Vallabh Minikel, Simon Mead, Sabina Capellari et al.|Neurology|2019Cited by 111
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
<scp>AZP2006</scp> in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease ProgressionJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|Movement Disorders|2025Cited by 0